Tolazamide (Tolanase - Upjohn), a sulphonylurea compound, was introduced about 3 years ago for the treatment of maturity-onset diabetes. This article compares it with the other drugs of this group which we have previously discussed.1–3
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.